A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial.

Autor: MacArthur RD (AUTHOR), Novak RM (AUTHOR), Peng G (AUTHOR), Chen L (AUTHOR), Xiang Y (AUTHOR), Hullsiek KH (AUTHOR), Kozal MJ (AUTHOR), van den Berg-Wolf M (AUTHOR), Henely C (AUTHOR), Schmetter B (AUTHOR), Dehlinger M (AUTHOR), CPCRA 058 Study Team (CORPORATE AUTHOR), Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) (CORPORATE AUTHOR)

Publikováno v: Lancet. 12/16/2006, Vol. 368 Issue 9553, p2125-2135. 11p.